HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
methyl syringate
Networked:
2
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Hydrocarbons: 1713
Cyclic Hydrocarbons: 97
Aromatic Hydrocarbons: 291
Benzene Derivatives: 17
Phenols: 677
Hydroxybenzoates: 18
Gallic Acid: 845
methyl syringate: 2
Benzoates: 426
Hydroxybenzoates: 18
Gallic Acid: 845
methyl syringate: 2
Carboxylic Acids: 973
Hydroxy Acids: 94
Hydroxybenzoates: 18
Gallic Acid: 845
methyl syringate: 2
Carbocyclic Acids
Benzoates: 426
Hydroxybenzoates: 18
Gallic Acid: 845
methyl syringate: 2
Experts
1.
Jin, Mirim
: 1 article (03/2016)
2.
Lee, YoungJoo
: 1 article (03/2016)
3.
Park, Joonwoo
: 1 article (03/2016)
4.
Rhyu, Mee-Ra
: 1 article (03/2016)
5.
Shim, Myeong Kuk
: 1 article (03/2016)
Related Diseases
1.
Hypoxia (Hypoxemia)
03/15/2016 - "
This study examined the effects of methyl syringate on hypoxia-induced COX-2 in human distal lung epithelial A549 cells.
"
03/15/2016 - "
The effect of the methyl syringate on suppression of hypoxia-induced COX-2 in A549 cells were determined by Western blot and/or quantitative real-time polymerase chain reaction.
"
03/15/2016 - "
These findings suggest that methyl syringate could be effective to suppress hypoxia-induced inflammation and indicate an additional functional effect of methyl syringate.
"
03/15/2016 - "
Methyl syringate, a TRPA1 agonist represses hypoxia-induced cyclooxygenase-2 in lung cancer cells.
"
03/15/2016 - "
Methyl syringate suppressed hypoxia-induced COX-2 protein and mRNA expression and promoter activity and reduced hypoxia-induced cell migration and invasion and secretion of vascular endothelial growth factor.
"
2.
Lung Neoplasms (Lung Cancer)
03/15/2016 - "
Methyl syringate, a TRPA1 agonist represses hypoxia-induced cyclooxygenase-2 in lung cancer cells.
"
3.
Insulin Resistance
06/12/2023 - "
Methyl Syringate Stimulates Glucose Uptake by Inhibiting Protein Tyrosine Phosphatases Relevant to Insulin Resistance.
"
4.
Inflammation (Inflammations)
03/15/2016 - "
These findings suggest that methyl syringate could be effective to suppress hypoxia-induced inflammation and indicate an additional functional effect of methyl syringate.
"
5.
Type 2 Diabetes Mellitus (MODY)
06/12/2023 - "
Taken together, our results suggest that methyl syringate, a dual-targeting inhibitor of PTPN2 and PTPN6, is a promising therapeutic candidate for the treatment or prevention of type 2 diabetes.
"
Related Drugs and Biologics
1.
Cyclooxygenase 2 (Cyclooxygenase-2)
2.
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
3.
Protein Tyrosine Phosphatases
4.
Messenger RNA (mRNA)
5.
Proteins (Proteins, Gene)
6.
Glucose (Dextrose)